+86 27 8798 8585
| |

About Us

You are at the location of:Home - About Us - Organization



At present, BravoVax has invested tens of millions RMB and constructed 4 technology sub-platforms that involves 2 pilot production lines. Furthermore, BravoVax seeks to construct China’s first high-end human vaccines manufacturing base in compliance with US FDA and cGMP of EU in Biopark located in Wuhan, China.